BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Iran executes two men who tried storming military facility during January protest crackdown - 2IDF confirms Iranian missile fragments hit near Kirya, multiple cars ablaze in Ramat Gan
- 3Dancing through the crackdown: The satirical song soundtracking post-Khamenei Iran
- 4Latvia seeks emergency UN meeting over Russian missile attack on Lviv
- 5Pick Your Favored kind of soup
- Netflix is releasing a documentary on Elizabeth Smart. What to know about her kidnapping, rescue and where she is now.
- Golan resident convicted of spying for Iran after passing tank movement, missile-impact data
- Ukraine: Russians abduct 50 Ukrainians from border village in Sumy
- German Court Rejects Bid To Force BMW and Mercedes-Benz To Stop Selling New Combustion-Engine Cars After 2030
- Nearly half of reindeer have been wiped out and armadillos are in Iowa. Here’s how animals are weathering warming holidays
- 8 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN
- Virtual National Science Foundation internships aren’t just a pandemic stopgap – they can open up opportunities for more STEM students
- The risk of falling space junk hitting airplanes is on the rise, experts warn
- Historical mysteries solved by science in 2025
